Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Mopec Releases Whitepaper Examining "The Future of Mass Fatality Preparedness"


MADISON HEIGHTS, Mich., Oct. 19, 2020 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, and the growing need for mass fatality response, Mopec?a leading provider of high-quality pathology, anatomy, mortuary and necropsy equipment and products?today released its The Future of Mass Fatality Preparedness whitepaper. The report analyzes the rise of mass fatality events, the COVID-19 pandemic response and the growing need for emergency preparedness plans.

"There are countless lessons that can be learned from recent mass fatality events," said Jay Troger, CEO at Mopec. "We've spoken to our customers, examined recent coverage and reviewed industry trends in order to develop this whitepaper and create resource for organizations to use as they plan and prepare for the next crisis."

The whitepaper includes a list of questions that organizations should ask themselves to assess their level of catastrophe preparedness, as well as a crisis planning outline and supplies checklist. The Mopec team also provides global natural disaster statistics and an in-depth analysis of the first wave of the COVID-19 pandemic.

"Many organizations across the country were caught off guard when the COVID-19 pandemic hit earlier this year," said Dr. Joyce deJong, medical examiner for 12 Michigan counties. "The response revealed a great deal about what agencies and organizations should do when faced with a mass fatality or natural disaster. This is the time for an honest, thoughtful review of preparedness plans so that we may identify gaps in our processes and develop best practices."

In addition to providing the whitepaper, Mopec's experienced team of professionals is available to provide customized emergency preparedness, mass fatality response and surge capacity products and services. To access the whitepaper or learn more about Mopec's products and services, visit Mopec.com.

About Mopec
Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Better By Design and specializes in solutions for hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit www.mopec.com.

MEDIA CONTACT:
Lisa Lark
313.410.8477
[email protected]

SOURCE Mopec


These press releases may also interest you

at 16:16
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

at 16:05
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company's Form 10-Q can...

at 14:41
Striking new work from the acclaimed visual artist behind the Covid flags on the Mall opened to the public today at Freedom Plaza in Washington, D.C. Suzanne Brennan Firstenberg launched her latest work "alienable right to life," at a moving opening...

at 14:00
For the first quarter ended March 31, 2024, Desjardins Group, North America's largest financial cooperative group, recorded surplus earnings before member dividends of $855 million, up $513 million from the same quarter of 2023. All business segments...

at 12:15
The "Global Car Subscription Market: Analysis By Vehicle Type, By Subscription Period, By Service Provider, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to...

at 11:30
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff...



News published on and distributed by: